4//SEC Filing
ALLERGAN INC 4
Accession 0000850693-05-000101
CIK 0000850693operating
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 5:50 PM ET
Size
10.4 KB
Accession
0000850693-05-000101
Insider Transaction Report
Form 4
ALLERGAN INC(AGN)
EVANS HANDEL
Director
Transactions
- Award
Phantom Stock Units
2005-06-08$82.20/sh+33.8$2,778→ 27,817.08 total→ Common Stock (0 underlying) - Award
Phantom Stock Units
2005-07-01$84.62/sh+88.63$7,500→ 27,905.71 total→ Common Stock (0 underlying) - Award
Phantom Stock Units
2005-07-01$84.62/sh+29.54$2,500→ 27,935.25 total→ Common Stock (0 underlying)
Footnotes (4)
- [F1]Converts to common stock on a 1-for-1 basis.
- [F2]Phantom stock units accrued under the Allergan, Inc. Dividend Reinvestment Plan, exempt transaction under Rule 16a-11.
- [F3]Phantom stock units are to be settled 100% in stock upon the reporting person's retirement as an Allergan, Inc. director.
- [F4]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program in lieu of cash for quarterly portion of annual retainer.
Documents
Issuer
ALLERGAN INC
CIK 0000850693
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000850693
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 5:50 PM ET
- Size
- 10.4 KB